UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
25
NOTIFICATION
OF REMOVAL FROM LISTING AND/OR
REGISTRATION
UNDER SECTION 12(b) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Commission
File Number 001-32526
(Exact
name of Issuer as specified in its charter, and name of Exchange where security
is listed and/or registered)
2188
West 2200 South
Salt
Lake City, Utah 84119
(Address,
including zip code, and telephone number, including area code, of Issuer’s
principal executive offices)
Common
Stock, $0.001 par value
(Description
of class of securities)
Please
place an X in the box to designate the rule provision relied upon to strike the
class of securities from listing and registration:
o 17
CFR 240.12d2-2(a)(1)
o 17
CFR 240.12d2-2(a)(2)
o 17
CFR 240.12d2-2(a)(3)
o 17
CFR 240.12d2-2(a)(4)
o Pursuant
to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the
class of securities from listing and/or withdraw registration on the
Exchange.
x Pursuant
to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange
and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal
of the class of securities from listing and registration on the
Exchange.
Pursuant
to the requirements of the Securities Exchange Act of 1934, BSD MEDICAL
CORPORATION certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing the Form 25 and has caused this notification
to be signed on its behalf by the undersigned duly authorized
person.
|
April
22, 2008
|
By:
|
/s/
Hyrum A. Mead
|
|
President
|
|
Date
|
|
Name
|
|
Title
|